Bridge Funding - Genetic variant-based drug discovery targeting conserved pathways of aging

过渡资金——针对保守的衰老途径的基于基因变异的药物发现

基本信息

  • 批准号:
    10733650
  • 负责人:
  • 金额:
    $ 44.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-15 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT (ADMINISTRATIVE SUPPLEMENT) Aging is the most important risk factor for common human diseases, such as diabetes, cardiovascular disease, and cancer. Hence, targeting basic mechanisms of aging rather than individual diseases is a rational strategy to develop treatments of age-related multi-morbidity. To test the validity of this approach investigators in this U19 leverage the human centenarian resource at the Albert Einstein College of Medicine to identify rare genetic variants associated with extreme human longevity to identify potential drug targets for promoting healthy aging. Using resequencing data of 400 candidate genes in 450 centenarians and 550 controls we identified, in the previous funding period, rare, functional genetic variants and associated pathways enriched in centenarians and potentially important for healthy longevity, including IGF-1, SIRT6, FOXO3A, NF-kB and SMAD3. Importantly, analysis of new, whole exome sequences of 555 centenarians and 508 controls, provided additional candidate variants, e.g., BLM, USP35, UBE3C. A number of the rare variant candidates were further characterized and evaluated functionally in human ES cells and differentiated lineages. We also generated mouse models of some of the variants for analysis of phenotypes relevant for late-life human health and subsequently used the ES cell and mouse model results as leads for developing assays and testing small molecules targeting the pathways affected by these rare variants. Interestingly, many of the rare variants and/or affected pathways could be linked to the DNA damage response, including cellular senescence. Based on the demonstrated success of our approach we now have expanded our whole exome-sequenced cohort to increase robustness of the analysis, identify additional variants and study candidate pathways through RNA-seq, functionalize additional candidate variants in ESCs and generate more mouse models. This should allow us to greatly extend the number of validated therapeutic targets for drug development.
项目摘要/摘要(行政补充)

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Senescent intervertebral disc cells exhibit perturbed matrix homeostasis phenotype.
  • DOI:
    10.1016/j.mad.2017.08.007
  • 发表时间:
    2017-09
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Ngo K;Patil P;McGowan SJ;Niedernhofer LJ;Robbins PD;Kang J;Sowa G;Vo N
  • 通讯作者:
    Vo N
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation.
  • DOI:
    10.1371/journal.pbio.2004663
  • 发表时间:
    2018-06
  • 期刊:
  • 影响因子:
    9.8
  • 作者:
    Zhao J;Zhang L;Mu X;Doebelin C;Nguyen W;Wallace C;Reay DP;McGowan SJ;Corbo L;Clemens PR;Wilson GM;Watkins SC;Solt LA;Cameron MD;Huard J;Niedernhofer LJ;Kamenecka TM;Robbins PD
  • 通讯作者:
    Robbins PD
Mouse Models of Accelerated Cellular Senescence.
  • DOI:
    10.1007/978-1-4939-8931-7_17
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yousefzadeh MJ;Melos KI;Angelini L;Burd CE;Robbins PD;Niedernhofer LJ
  • 通讯作者:
    Niedernhofer LJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAN VIJG其他文献

JAN VIJG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAN VIJG', 18)}}的其他基金

ConProject-001
ConProject-001
  • 批准号:
    10600806
  • 财政年份:
    2017
  • 资助金额:
    $ 44.41万
  • 项目类别:
Development of novel therapeutics targeting the identified pathways associated with human longevity
针对已确定的与人类长寿相关的途径开发新疗法
  • 批准号:
    10714394
  • 财政年份:
    2017
  • 资助金额:
    $ 44.41万
  • 项目类别:
ConProject-003
ConProject-003
  • 批准号:
    10653286
  • 财政年份:
    2017
  • 资助金额:
    $ 44.41万
  • 项目类别:
ConProject-005
ConProject-005
  • 批准号:
    10653292
  • 财政年份:
    2017
  • 资助金额:
    $ 44.41万
  • 项目类别:
ConProject-006
ConProject-006
  • 批准号:
    10653296
  • 财政年份:
    2017
  • 资助金额:
    $ 44.41万
  • 项目类别:
Genetic variant-based drug discovery targeting conserved pathways of aging
针对保守的衰老途径的基于遗传变异的药物发现
  • 批准号:
    9916672
  • 财政年份:
    2017
  • 资助金额:
    $ 44.41万
  • 项目类别:
Genetic variant-based drug discovery targeting conserved pathways of aging
针对保守的衰老途径的基于遗传变异的药物发现
  • 批准号:
    9359668
  • 财政年份:
    2017
  • 资助金额:
    $ 44.41万
  • 项目类别:
Validation and characterization of the identified variants associated with human longevity in mouse models
在小鼠模型中验证和表征与人类长寿相关的已识别变异
  • 批准号:
    10714393
  • 财政年份:
    2017
  • 资助金额:
    $ 44.41万
  • 项目类别:
ConProject-002
ConProject-002
  • 批准号:
    10600807
  • 财政年份:
    2017
  • 资助金额:
    $ 44.41万
  • 项目类别:
Admin-Core-001
管理核心-001
  • 批准号:
    10600778
  • 财政年份:
    2017
  • 资助金额:
    $ 44.41万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 44.41万
  • 项目类别:
Parkinson's disease and aging affect neural activation during continuous gait alterations to the split-belt treadmill: An [18F] FDG PET Study.
帕金森病和衰老会影响分体带跑步机连续步态改变期间的神经激活:[18F] FDG PET 研究。
  • 批准号:
    400097
  • 财政年份:
    2019
  • 资助金额:
    $ 44.41万
  • 项目类别:
The elucidation of the mechanism by which intestinal epithelial cells affect impaired glucose tolerance during aging
阐明衰老过程中肠上皮细胞影响糖耐量受损的机制
  • 批准号:
    19K09017
  • 财政年份:
    2019
  • 资助金额:
    $ 44.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Does aging of osteocytes adversely affect bone metabolism?
骨细胞老化会对骨代谢产生不利影响吗?
  • 批准号:
    18K09531
  • 财政年份:
    2018
  • 资助金额:
    $ 44.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Links between affect, executive function, and prefrontal structure in aging: A longitudinal analysis
衰老过程中情感、执行功能和前额叶结构之间的联系:纵向分析
  • 批准号:
    9766994
  • 财政年份:
    2018
  • 资助金额:
    $ 44.41万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 44.41万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 44.41万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 44.41万
  • 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
  • 批准号:
    9925164
  • 财政年份:
    2016
  • 资助金额:
    $ 44.41万
  • 项目类别:
Experimental Model of Depression in Aging: Insomnia, Inflammation, and Affect Mechanisms
衰老过程中抑郁症的实验模型:失眠、炎症和影响机制
  • 批准号:
    9345997
  • 财政年份:
    2016
  • 资助金额:
    $ 44.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了